Cash flow at 31/03/15 was $2mn when the company had to do another round of CR in June 2015. Based on a cash burn of $1mn to $1.5mn per quarter; projected Cash flow around 31/03/16 could come to similar $2mn to $2.5mn level. Cannot see any revenue from sale of BIT225 between now and then that will boost cash balances up. Clinical trials still have many phases and years to go!
This raises a bright new prospect of a fresh round of CR for BIT. Good luck
Another 20% to 25% downside could happen within few days once the effect of yesterdays ANN waters down; IMHO, DYOR
Your thoughts wonderful people
Capital raising possiblity
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
